Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02559804 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Study Registry of Peripheral Neuroblastic Tumours Presenting With Spinal Canal Involvement (SCI)

Study acronym: NB-SCI
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 2017 to May 2029
    • Study completion date: Apr 2018 to May 2029
    v4
  2. Primary completion date: Dec 2016 to Dec 2017v3
  3. Primary completion date: May 2016 to Dec 2016
    • Study completion date: Apr 2017 to Apr 2018
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To describe the natural history of peripheral neuroblastic tumour presenting with SCI and evaluate the combined effects of different risk factors on the eventual neurologic and orthopaedic outcomes
Trial Details
NCT Number NCT02559804
Lead Sponsor Associazione Italiana Ematologia Oncologia Pediatrica
Collaborators: Istituto Giannina Gaslini
Conditions
(from sponsor)		 Neuroblastic Tumors
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov